$HR
Healthcare Realty Trust Inc

2013 Q1 Form 10-Q Financial Statement

#000144530513001207 Filed on May 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $76.86M $70.68M
YoY Change 8.75% -0.3%
Cost Of Revenue $29.40M $28.30M
YoY Change 3.89% 3.28%
Gross Profit $50.80M $47.70M
YoY Change 6.5% 9.15%
Gross Profit Margin 66.09% 67.49%
Selling, General & Admin $6.500M $5.200M
YoY Change 25.0% -13.33%
% of Gross Profit 12.8% 10.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.20M $16.70M
YoY Change 8.98% -23.74%
% of Gross Profit 35.83% 35.01%
Operating Expenses $30.30M $28.10M
YoY Change 7.83% 8.08%
Operating Profit $12.45M $10.45M
YoY Change 19.18% -12.3%
Interest Expense -$19.50M -$18.10M
YoY Change 7.73% -18.1%
% of Operating Profit -156.59% -173.22%
Other Income/Expense, Net $8.000K -$11.01M
YoY Change -100.07% 13.18%
Pretax Income $900.0K $1.400M
YoY Change -35.71% -121.88%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $1.351M -$315.0K
YoY Change -528.89% -114.65%
Net Earnings / Revenue 1.76% -0.45%
Basic Earnings Per Share $0.01 $0.00
Diluted Earnings Per Share $0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 217.1M shares 228.9M shares
Diluted Shares Outstanding 218.9M shares 228.9M shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $94.20M $6.600M
YoY Change 1327.27% 120.0%
Cash & Equivalents $121.0M $35.12M
Short-Term Investments
Other Short-Term Assets $7.000M $44.90M
YoY Change -84.41%
Inventory
Prepaid Expenses
Receivables $18.00M $6.500M
Other Receivables $0.00 $32.30M
Total Short-Term Assets $94.20M $90.30M
YoY Change 4.32% 2910.0%
LONG-TERM ASSETS
Property, Plant & Equipment $2.217B $2.252B
YoY Change -1.59% 7.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.300M
YoY Change
Other Assets $22.30M $26.80M
YoY Change -16.79% 60.48%
Total Long-Term Assets $2.496B $2.367B
YoY Change 5.44% 3.21%
TOTAL ASSETS
Total Short-Term Assets $94.20M $90.30M
Total Long-Term Assets $2.496B $2.367B
Total Assets $2.590B $2.458B
YoY Change 5.4% 7.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.50M $47.00M
YoY Change -3.19% -15.77%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.50M $47.00M
YoY Change -3.19% -15.77%
LONG-TERM LIABILITIES
Long-Term Debt $1.415B $1.419B
YoY Change -0.25% 9.71%
Other Long-Term Liabilities $58.00M $52.30M
YoY Change 10.9% 15.2%
Total Long-Term Liabilities $1.473B $1.471B
YoY Change 0.15% 9.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.50M $47.00M
Total Long-Term Liabilities $1.473B $1.471B
Total Liabilities $1.245B $918.1M
YoY Change 35.56% -34.15%
SHAREHOLDERS EQUITY
Retained Earnings -$664.6M -$509.1M
YoY Change 30.55%
Common Stock $1.991B $2.045B
YoY Change -2.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.329B $1.536B
YoY Change
Total Liabilities & Shareholders Equity $2.590B $2.458B
YoY Change 5.4% 7.01%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income $1.351M -$315.0K
YoY Change -528.89% -114.65%
Depreciation, Depletion And Amortization $18.20M $16.70M
YoY Change 8.98% -23.74%
Cash From Operating Activities $27.94M $26.11M
YoY Change 7.02% 3.96%
INVESTING ACTIVITIES
Capital Expenditures -$25.00M -$44.50M
YoY Change -43.82% 74.51%
Acquisitions
YoY Change
Other Investing Activities -$23.20M $33.80M
YoY Change -168.64% -175.11%
Cash From Investing Activities -$92.13M -$220.8M
YoY Change -58.28% 675.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$105.5M $9.916M
YoY Change -1163.71% -104.9%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $169.2M $160.3M
YoY Change 5.52% -11.66%
NET CHANGE
Cash From Operating Activities $27.94M $26.11M
Cash From Investing Activities -$92.13M -$220.8M
Cash From Financing Activities $169.2M $160.3M
Net Change In Cash $105.0M -$34.37M
YoY Change -405.5% -119.29%
FREE CASH FLOW
Cash From Operating Activities $27.94M $26.11M
Capital Expenditures -$25.00M -$44.50M
Free Cash Flow $52.94M $70.61M
YoY Change -25.02% 39.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
66929000 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
63443000 USD
CY2013Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P7Y9M18D
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1991217000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1885836000 USD
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition
4323000 USD
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition
1002000 USD
CY2012Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
391000 USD
CY2013Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
565000 USD
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1245000 USD
CY2012Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1214000 USD
CY2012Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
95000 USD
CY2013Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
50000 USD
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
725000 shares
CY2013Q1 us-gaap Assets
Assets
2590204000 USD
CY2012Q4 us-gaap Assets
Assets
2414090000 USD
CY2012Q4 us-gaap Assets Held For Sale Property Plant And Equipment
AssetsHeldForSalePropertyPlantAndEquipment
0 USD
CY2013Q1 us-gaap Assets Held For Sale Property Plant And Equipment
AssetsHeldForSalePropertyPlantAndEquipment
925000 USD
CY2013Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
925000 USD
CY2013Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Noncurrent
AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
21138000 USD
CY2012Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2578000 USD
CY2013Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1696000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15956000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120958000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69491000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35120000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
105002000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-34371000 USD
CY2013Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1135781000 USD
CY2013Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
88000 USD
CY2012Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1037359000 USD
CY2013Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1135693000 USD
CY2012Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
11006000 USD
CY2013Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
12453000 USD
CY2013Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
40936000 USD
CY2012Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
39095000 USD
CY2012Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27128000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2012Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
60227000 USD
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
64172000 USD
CY2012Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1034956000 USD
CY2013Q1 us-gaap Debt Instrument Interest Rate Stated Percentage Rate Range Maximum
DebtInstrumentInterestRateStatedPercentageRateRangeMaximum
0.1095
CY2013Q1 us-gaap Debt Instrument Interest Rate Stated Percentage Rate Range Minimum
DebtInstrumentInterestRateStatedPercentageRateRangeMinimum
0.1085
CY2012Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-2403000 USD
CY2013Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
28390000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18200000 USD
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16700000 USD
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1100000 USD
CY2013Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1200000 USD
CY2013Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
5400000 USD
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
8300000 USD
CY2012Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
13229000 USD
CY2013Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
32333000 USD
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2013Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
6569000 USD
CY2012Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
9370000 USD
CY2012Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
22628000 USD
CY2013Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
23904000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
65000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
88000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
161000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
127000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
236000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
317000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
250000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
198000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Rental Income
DisposalGroupIncludingDiscontinuedOperationRentalIncome
567000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Rental Income
DisposalGroupIncludingDiscontinuedOperationRentalIncome
434000 USD
CY2013Q1 us-gaap Dividends
Dividends
32518000 USD
CY2012Q1 us-gaap Dividends
Dividends
41502000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
125924000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
131127000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
421130000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
408858000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
290003000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
282934000 USD
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6007000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6448000 USD
CY2012Q4 us-gaap Incentive To Lessee
IncentiveToLessee
880000 USD
CY2013Q1 us-gaap Incentive To Lessee
IncentiveToLessee
802000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-438000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1314000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-430000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1347000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.00
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.00
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
123000 USD
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
37000 USD
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2012Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1045000 USD
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
76000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1331000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1956000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3181000 USD
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5428000 USD
CY2013Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-143000 USD
CY2012Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
1209000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
10212000 USD
CY2012Q1 us-gaap Interest Paid
InterestPaid
9916000 USD
CY2013Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2094322000 USD
CY2012Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2044113000 USD
CY2012Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
27000 USD
CY2013Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
8000 USD
CY2012Q4 us-gaap Land
Land
183651000 USD
CY2013Q1 us-gaap Land
Land
181881000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1145931000 USD
CY2013Q1 us-gaap Liabilities
Liabilities
1244639000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2414090000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2590204000 USD
CY2013Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
116000 USD
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
522373000 USD
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
29732000 USD
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
99963000 USD
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
404696000 USD
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
72625000 USD
CY2013Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6392000 USD
CY2013Q1 us-gaap Minority Interest
MinorityInterest
14803000 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
10329000 USD
CY2013Q1 us-gaap Minority Interest In Net Income Loss Limited Partnerships
MinorityInterestInNetIncomeLossLimitedPartnerships
33000 USD
CY2012Q1 us-gaap Minority Interest In Net Income Loss Limited Partnerships
MinorityInterestInNetIncomeLossLimitedPartnerships
8000 USD
CY2013Q1 us-gaap Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
0.9920
CY2012Q4 us-gaap Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
0.9993
CY2013Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization and Description of Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Healthcare Trust of America, Inc., a Maryland corporation, was incorporated on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;20, 2006</font><font style="font-family:inherit;font-size:10pt;">. We were initially capitalized on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;28, 2006</font><font style="font-family:inherit;font-size:10pt;"> and consider that to be our date of inception. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are a fully integrated, self-administered and internally managed real estate investment trust, or REIT, primarily focused on acquiring, owning and operating high-quality medical office buildings that are predominantly located on or aligned with campuses of nationally or regionally recognized healthcare systems. We are one of the largest public REITs focused on medical office buildings in the United States based on gross leasable area, or GLA, and have strong industry relationships, a stable and diversified tenant mix and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments and to provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we (i) target mid-sized acquisitions of high-quality medical office buildings in markets with dominant healthcare systems, attractive demographics and that complement our existing portfolio, (ii) actively manage our balance sheet to maintain flexibility with conservative leverage, and (iii) seek internal growth through proactive asset management, leasing and property management oversight. We have qualified to be taxed as a REIT for federal income tax purposes and we intend to continue to be taxed as a REIT. We conduct substantially all of our operations through Healthcare Trust of America Holdings, LP, or our operating partnership.</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We invest primarily in high-quality medical office buildings in our target markets, and have acquired high-quality medical office buildings and other facilities that serve the healthcare industry with an aggregate purchase price of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.7 billion</font><font style="font-family:inherit;font-size:10pt;"> through </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2013</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2013</font><font style="font-family:inherit;font-size:10pt;">, our portfolio consisted of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">249</font><font style="font-family:inherit;font-size:10pt;"> medical office buildings and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">19</font><font style="font-family:inherit;font-size:10pt;"> other facilities that serve the healthcare industry, as well as a mortgage loan receivable secured by medical office buildings.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;6, 2012</font><font style="font-family:inherit;font-size:10pt;">, we listed our Class A common stock on the New York Stock Exchange, or the NYSE, under the symbol &#8220;HTA,&#8221; or the Listing. In accordance with an amendment to our charter approved by our stockholders on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;20, 2010</font><font style="font-family:inherit;font-size:10pt;">, all of our common stock was converted into Class A, Class B-1, Class B-2 and Class B-3 common stock. Our Class B common stock is identical to our Class A common stock except that our Class B common stock is not currently listed on a national securities exchange. The shares of our Class B-1 common stock converted into shares of our Class A common stock on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;6, 2012</font><font style="font-family:inherit;font-size:10pt;"> and our Class B-2 and B-3 common stock will convert to Class A common stock after the market closes on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;6, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;6, 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively, unless our Board of Directors elects to convert some or all of the shares prior to those dates.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our principal executive offices are located at 16435 N. Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.</font></div></div>
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
169190000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
160338000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92125000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-220814000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27937000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26105000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-315000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
1351000 USD
CY2013Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
20000000 USD
CY2012Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
20000000 USD
CY2013Q1 us-gaap Notes Receivable Net
NotesReceivableNet
20000000 USD
CY2012Q4 us-gaap Notes Receivable Net
NotesReceivableNet
20000000 USD
CY2013Q1 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
2 Acquisitions
CY2012Q4 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
11309000 USD
CY2013Q1 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
11211000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
10449000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12255000 USD
CY2013Q1 us-gaap Other Liabilities
OtherLiabilities
24237000 USD
CY2012Q4 us-gaap Other Liabilities
OtherLiabilities
24450000 USD
CY2012Q4 us-gaap Other Restricted Assets
OtherRestrictedAssets
17623000 USD
CY2013Q1 us-gaap Other Restricted Assets
OtherRestrictedAssets
17479000 USD
CY2013Q1 us-gaap Payments For Deposits On Real Estate Acquisitions
PaymentsForDepositsOnRealEstateAcquisitions
0 USD
CY2012Q1 us-gaap Payments For Deposits On Real Estate Acquisitions
PaymentsForDepositsOnRealEstateAcquisitions
2810000 USD
CY2013Q1 us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
92000 USD
CY2012Q1 us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
328000 USD
CY2012Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9916000 USD
CY2013Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
272000 USD
CY2013Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2179000 USD
CY2012Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4777000 USD
CY2012Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22246000 USD
CY2013Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
30856000 USD
CY2013Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
348000 USD
CY2012Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
30000 USD
CY2012Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6695000 USD
CY2013Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3739000 USD
CY2012Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
213900000 USD
CY2013Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
88529000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6831000 USD
CY2013Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
7107000 USD
CY2013Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To better present our real estate related balances, we have chosen to break out the details of real estate investments (net) in our balance sheet as opposed to disclosing the details in a footnote. In addition, we have reclassified certain accounts, as further discussed below, in our previously issued balance sheet to conform to current period presentation. In place leases and tenant relationship intangibles are now included in real estate investments (net) as lease intangibles. In addition, accounts and other receivables (net) have been combined with receivables and other assets (net). None of the revised reclassifications reflect corrections of any amounts. </font></div></div>
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
105749000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
297558000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
200000000 USD
CY2013Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
103000000 USD
CY2012Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
182000000 USD
CY2013Q1 us-gaap Profit Loss
ProfitLoss
1384000 USD
CY2012Q1 us-gaap Profit Loss
ProfitLoss
-307000 USD
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
225000 USD
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-174000 USD
CY2012Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
0 USD
CY2013Q1 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
21138000 USD
CY2012Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
349118000 USD
CY2013Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
368460000 USD
CY2012Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
2580648000 USD
CY2013Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
2663099000 USD
CY2012Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
2231530000 USD
CY2013Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
2294639000 USD
CY2013Q1 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
75807000 USD
CY2012Q1 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
69368000 USD
CY2012Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
3564000 USD
CY2013Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1909000 USD
CY2013Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
175000000 USD
CY2012Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
182000000 USD
CY2012Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2563000 USD
CY2013Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
127175000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-664607000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-633717000 USD
CY2013Q1 us-gaap Revenues
Revenues
76427000 USD
CY2012Q1 us-gaap Revenues
Revenues
70676000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4323000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1002000 USD
CY2012Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
19148000 USD
CY2013Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
0 USD
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
104558000 USD
CY2013Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2012Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2013Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
272000 USD
CY2012Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9916000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
1328853000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
1254266000 USD
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1343656000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1264595000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1567340000 USD
CY2012Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1535757000 USD
CY2013Q1 hta Disposal Group Including Discontinued Operation Land
DisposalGroupIncludingDiscontinuedOperationLand
5109000 USD
CY2013Q1 hta Disposal Group Including Discontinued Operation Lease Intangibles
DisposalGroupIncludingDiscontinuedOperationLeaseIntangibles
848000 USD
CY2013Q1 hta Disposal Group Including Discontinued Operation Receivables And Other Assets
DisposalGroupIncludingDiscontinuedOperationReceivablesAndOtherAssets
925000 USD
CY2012Q1 hta Exchange Listing Expenses And Other Charges
ExchangeListingExpensesAndOtherCharges
0 USD
CY2013Q1 hta Exchange Listing Expenses And Other Charges
ExchangeListingExpensesAndOtherCharges
4405000 USD
CY2013Q1 hta Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
5633000 USD
CY2012Q4 hta Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
5341000 USD
CY2013Q1 hta Inception To Date Business Acquisition Purchase Price Allocation Property
InceptionToDateBusinessAcquisitionPurchasePriceAllocationProperty
2700000000 USD
CY2013Q1 hta Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
-457000 USD
CY2012Q1 hta Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
3098000 USD
CY2013Q1 hta Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
-241000 USD
CY2012Q1 hta Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
800000 USD
CY2012Q1 hta Interest Expense Related To Mortgage Loans Payable And Credit Facility
InterestExpenseRelatedToMortgageLoansPayableAndCreditFacility
10106000 USD
CY2013Q1 hta Interest Expense Related To Mortgage Loans Payable And Credit Facility
InterestExpenseRelatedToMortgageLoansPayableAndCreditFacility
11157000 USD
CY2013Q1 hta Interest Income From Mortgage Notes Receivable And Other Income
InterestIncomeFromMortgageNotesReceivableAndOtherIncome
620000 USD
CY2013Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1606000 USD
CY2012Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-508000 USD
CY2012Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1801000 shares
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
228881000 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218904000 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228881000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217103000 shares
CY2012Q4 hta Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
13317000 USD
CY2013Q1 hta Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
17861000 USD
CY2013Q1 hta Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life
AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife
P8Y3M18D
CY2013Q1 hta Acquisition Related Expenses
AcquisitionRelatedExpenses
1025000 USD
CY2012Q1 hta Acquisition Related Expenses
AcquisitionRelatedExpenses
2321000 USD
CY2013Q1 hta Adjustments To Redeemable Noncontrolling Interests
AdjustmentsToRedeemableNoncontrollingInterests
1619000 USD
CY2012Q4 hta Deferred Costs Leasing Commissions Gross
DeferredCostsLeasingCommissionsGross
10554000 USD
CY2013Q1 hta Deferred Costs Leasing Commissions Gross
DeferredCostsLeasingCommissionsGross
10715000 USD
CY2012Q1 hta Depreciation And Amortization Including Deferred Financing Costs Above Below Market Leases Debt Discount Leasehold Interests Deferred Rent Receivable Note Receivable Closing Costs And Discount And Lease Inducements
DepreciationAndAmortizationIncludingDeferredFinancingCostsAboveBelowMarketLeasesDebtDiscountLeaseholdInterestsDeferredRentReceivableNoteReceivableClosingCostsAndDiscountAndLeaseInducements
26716000 USD
CY2013Q1 hta Depreciation And Amortization Including Deferred Financing Costs Above Below Market Leases Debt Discount Leasehold Interests Deferred Rent Receivable Note Receivable Closing Costs And Discount And Lease Inducements
DepreciationAndAmortizationIncludingDeferredFinancingCostsAboveBelowMarketLeasesDebtDiscountLeaseholdInterestsDeferredRentReceivableNoteReceivableClosingCostsAndDiscountAndLeaseInducements
28564000 USD
CY2013Q1 hta Derivative Financial Instruments Termination Payments
DerivativeFinancialInstrumentsTerminationPayments
1195000 USD
CY2012Q1 hta Derivative Financial Instruments Termination Payments
DerivativeFinancialInstrumentsTerminationPayments
0 USD
CY2013Q1 hta Disposal Group Including Discontinued Operation Building And Building Improvements
DisposalGroupIncludingDiscontinuedOperationBuildingAndBuildingImprovements
15181000 USD
CY2012Q1 hta Disposal Group Including Discontinued Operation Depreciation And Amortization
DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
229000 USD
CY2013Q1 hta Disposal Group Including Discontinued Operation Depreciation And Amortization
DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
171000 USD
CY2012Q1 hta Interest Income From Mortgage Notes Receivable And Other Income
InterestIncomeFromMortgageNotesReceivableAndOtherIncome
1308000 USD
CY2012Q4 hta Lease Intangibles
LeaseIntangibles
352884000 USD
CY2013Q1 hta Lease Intangibles
LeaseIntangibles
365758000 USD
CY2013Q1 hta Non Traded Reit Expenses
NonTradedReitExpenses
0 USD
CY2012Q1 hta Non Traded Reit Expenses
NonTradedReitExpenses
2143000 USD
CY2012Q1 hta Noncash Debt Issuance Costs
NoncashDebtIssuanceCosts
0 USD
CY2013Q1 hta Noncash Debt Issuance Costs
NoncashDebtIssuanceCosts
528000 USD
CY2013Q1 hta Note Receivable Tenant
NoteReceivableTenant
3260000 USD
CY2012Q4 hta Note Receivable Tenant
NoteReceivableTenant
3287000 USD
CY2013Q1 hta Number Of Promissory Notes Secured By Office Buildings
NumberOfPromissoryNotesSecuredByOfficeBuildings
4 promissory_notes
CY2013Q1 hta Off Market Lease Unfavorable Gross
OffMarketLeaseUnfavorableGross
16844000 USD
CY2012Q4 hta Off Market Lease Unfavorable Gross
OffMarketLeaseUnfavorableGross
16650000 USD
CY2013Q1 hta Offering Costs Transferred To Equity
OfferingCostsTransferredToEquity
1191000 USD
CY2012Q1 hta Offering Costs Transferred To Equity
OfferingCostsTransferredToEquity
0 USD
CY2013Q1 hta Other Intangibles Net
OtherIntangiblesNet
43069000 USD
CY2012Q4 hta Other Intangibles Net
OtherIntangiblesNet
44011000 USD
CY2012Q1 hta Proceeds From Security Deposits
ProceedsFromSecurityDeposits
198000 USD
CY2013Q1 hta Proceeds From Security Deposits
ProceedsFromSecurityDeposits
0 USD
CY2012Q1 hta Real Estate Previously Paid Deposits
RealEstatePreviouslyPaidDeposits
3800000 USD
CY2013Q1 hta Real Estate Previously Paid Deposits
RealEstatePreviouslyPaidDeposits
0 USD
CY2013Q1 hta Receivable Weighted Average Interest Rate
ReceivableWeightedAverageInterestRate
0.1457
CY2012Q4 hta Receivables And Other Assets Net
ReceivablesAndOtherAssetsNet
84970000 USD
CY2013Q1 hta Receivables And Other Assets Net
ReceivablesAndOtherAssetsNet
93134000 USD
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001360604
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
HEALTHCARE TRUST OF AMERICA, INC.

Files In Submission

Name View Source Status
0001445305-13-001207-index-headers.html Edgar Link pending
0001445305-13-001207-index.html Edgar Link pending
0001445305-13-001207.txt Edgar Link pending
0001445305-13-001207-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
hta-20130331.xml Edgar Link completed
hta-20130331.xsd Edgar Link pending
hta-20130331_cal.xml Edgar Link unprocessable
hta-20130331_def.xml Edgar Link unprocessable
hta-20130331_lab.xml Edgar Link unprocessable
hta-20130331_pre.xml Edgar Link unprocessable
hta201333110-q.htm Edgar Link pending
hta2013331ex311.htm Edgar Link pending
hta2013331ex312.htm Edgar Link pending
hta2013331ex321.htm Edgar Link pending
hta2013331ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending